Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 16(10): e0258755, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34669748

RESUMO

The General Organization of the Veterinary Services in Egypt has adopted a sheeppox vaccination policy to control lumpy skin disease (LSD) in cattle. Over the course of the last two years, recurrent outbreaks were reported, with animals showing severe clinical signs and consequentially higher fatalities than that of cases reported in previous LSD outbreaks. A total of 1050 cattle showing typical clinical signs suggestive of LSD were clinically and pathologically investigated during 2017-2018. Skin nodules were collected and lumpy skin disease virus (LSDV) was screened in collected skin samples using PCR for the RPO-30 gene. Furthermore, the entire P32 protein coding gene was sequenced. Histopathology and immunohistochemistry of the skin nodules were also conducted. The obtained results showed an overall mortality rate of 6.86%. LSDV was confirmed in all the examined nodules as evidenced by immunohistochemistry and positive PCR amplification of the RPO30 gene. Sequencing analysis of the P32 gene revealed a highly conserved nature and genetic stability of the LSDV. The results of the present study show that the current vaccination protocol was not effective for a multitude of reasons. These results also serve as evidence for a strong recommendation of an amendment of homologous vaccine use aside from a complete coverage of cattle populations in order to reduce the incidence of LSD among cattle population in Egypt.


Assuntos
Surtos de Doenças/veterinária , Doença Nodular Cutânea/epidemiologia , Vírus da Doença Nodular Cutânea/classificação , Vacinação/veterinária , Proteínas Virais/genética , Animais , Bovinos , Egito/epidemiologia , Evolução Molecular , Feminino , Doença Nodular Cutânea/mortalidade , Doença Nodular Cutânea/virologia , Vírus da Doença Nodular Cutânea/genética , Vírus da Doença Nodular Cutânea/isolamento & purificação , Masculino , Mortalidade , Filogenia , Análise de Sequência de DNA
3.
AAPS PharmSciTech ; 21(8): 326, 2020 Nov 18.
Artigo em Inglês | MEDLINE | ID: mdl-33206259

RESUMO

Brucellosis is a common zoonotic infection, particularly in the developing world. The recommended treatment regimens for brucellosis involve the use of two medications such as doxycycline and curcumin in order to avoid relapses and prolonged use of these drugs. Doxycycline has excellent activity in the acidic phagolysosomal environment, while curcumin modulates the immune system function and macrophage activity. Due to the intracellular existence of Brucellae and the different anti-immune mechanisms of Brucella, the treatment of Brucella infection faces many limitations. The design of nanosystems is a promising treatment approach for brucellosis. The objective of this study was to design and evaluate the efficacy of in situ pH-responsive curcumin-loaded niosome hydrogel and doxycycline-loaded chitosan-sodium alginate nanoparticles as chemotherapeutic agents against brucellosis. The prepared formulae showed a spherical nano shape with a slow drug release pattern and small particle size. The prepared formulae were evaluated in vivo using Guinea pigs experimentally infected with Brucella melitensis biovar3. The prepared formula combination gave a significant high reduction rate of Brucella spleen viable count compared with that of untreated controls at p < 0.05. The results showed that the treatment schemes were not fully successful in eliminating Brucella infection in Guinea pigs; however, they significantly (p < 0.05) reduced the viable Brucella count in a shorter time and sub-therapeutic doses. Collectively the novel prepared formulae could be a successful therapy for the effective treatment of brucellosis infection at the recommended therapeutic doses. Graphical abstract.


Assuntos
Alginatos/química , Antibacterianos/uso terapêutico , Brucelose/tratamento farmacológico , Quitosana/química , Curcumina/uso terapêutico , Doxiciclina/uso terapêutico , Hidrogéis/química , Lipossomos , Nanopartículas/administração & dosagem , Animais , Antibacterianos/administração & dosagem , Antibacterianos/farmacologia , Brucella melitensis/efeitos dos fármacos , Curcumina/administração & dosagem , Curcumina/farmacologia , Doxiciclina/farmacologia , Cobaias
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...